Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2019

04.09.2019 | Original Article

Comparison of total versus subtotal gastrectomy for remnant gastric cancer

verfasst von: Hironobu Goto, Shingo Kanaji, Dai Otsubo, Taro Oshikiri, Masashi Yamamoto, Tetsu Nakamura, Satoshi Suzuki, Yasuhiro Fujino, Masahiro Tominaga, Yoshihiro Kakeji

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Completion gastrectomy (CG) is a common procedure for remnant gastric cancer (RGC). However, partial gastrectomy for gastric cancer has several benefits compared to total gastrectomy in terms of the quality of life. In this study, we evaluated the feasibility and advantage of subtotal resection of the remnant stomach (SR) for clinical stage IA RGC.

Methods

A total of 43 patients who underwent gastrectomy for clinical stage IA RGC were included. CG and SR were performed on 27 (62.8%) and 16 patients (37.2%), respectively. The short- and long-term outcomes, including the nutritional status, after CG and SR for clinical stage IA RGC were compared between the two groups.

Results

There were no significant differences in pathological stage or incidence of postoperative complications between the two groups. The decrease in body weight, body mass index, and serum albumin level was significantly lower in the SR group than in the CG group (P < 0.001, P = 0.025, and 0.008). In the SR group, there was no recurrence at the remaining lymph nodes or gastric stump. The 5-year overall survival rate was 87.8% in the CG group and 86.1% in the SR group, without a significant difference between the two groups (P = 0.959).

Conclusions

The present study showed the noninferiority of SR to CG based on surgical and oncological outcomes for clinical stage IA RGC. Furthermore, SR has an advantage over CG in terms of postoperative nutritional status. Therefore, SR could be an alternative elective treatment option for early RGC located around the anastomotic site.
Literatur
1.
Zurück zum Zitat Ikeda Y, Saku M, Kishihara F, Maehara Y (2005) Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 92:235–239CrossRef Ikeda Y, Saku M, Kishihara F, Maehara Y (2005) Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 92:235–239CrossRef
2.
Zurück zum Zitat Onodera H, Tokunaga A, Yoshiyuki T, Kiyama T, Kato S, Matsukura N, Masuda G, Tajiri T (2004) Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepatogastroenterology 51:82–85PubMed Onodera H, Tokunaga A, Yoshiyuki T, Kiyama T, Kato S, Matsukura N, Masuda G, Tajiri T (2004) Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepatogastroenterology 51:82–85PubMed
3.
Zurück zum Zitat Nozaki I, Nasu J, Kudo Y, Tanaka M, Nishimura R, Kurita A (2010) Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg 34:1548–1554CrossRef Nozaki I, Nasu J, Kudo Y, Tanaka M, Nishimura R, Kurita A (2010) Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg 34:1548–1554CrossRef
4.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma-3rd English edition. Gastric Cancer 14:101–112CrossRef Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma-3rd English edition. Gastric Cancer 14:101–112CrossRef
5.
Zurück zum Zitat Tanigawa N, Nomura E, Lee SW, Kaminishi M, Sugiyama M, Aikou T, Kitajima M (2010) Current state of gastric stump carcinoma in Japan. World J Surg 34:1540–1547CrossRef Tanigawa N, Nomura E, Lee SW, Kaminishi M, Sugiyama M, Aikou T, Kitajima M (2010) Current state of gastric stump carcinoma in Japan. World J Surg 34:1540–1547CrossRef
6.
Zurück zum Zitat Takiguchi N, Takahashi M, Ikeda M, Inagawa S, Ueda S, Nobuoka T, Ota M, Iwasaki Y, Uchida N, Kodera Y, Nakada (2015) Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer 18:407–416CrossRef Takiguchi N, Takahashi M, Ikeda M, Inagawa S, Ueda S, Nobuoka T, Ota M, Iwasaki Y, Uchida N, Kodera Y, Nakada (2015) Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer 18:407–416CrossRef
7.
Zurück zum Zitat Takahashi M, Terashima M, Kawahira H, Nagai E, Uenosono Y, Kinami S, Nakata Y, Yoshida M, Aoyagi K, Kodera Y, Nakada K (2017) Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: use of the postgastrectomy syndrome assessment scale-45. World J Gastroenterol 23:2068–2076CrossRef Takahashi M, Terashima M, Kawahira H, Nagai E, Uenosono Y, Kinami S, Nakata Y, Yoshida M, Aoyagi K, Kodera Y, Nakada K (2017) Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: use of the postgastrectomy syndrome assessment scale-45. World J Gastroenterol 23:2068–2076CrossRef
8.
Zurück zum Zitat Japanese Gastric Cancer Association (2010) Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer 14:113–123CrossRef Japanese Gastric Cancer Association (2010) Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer 14:113–123CrossRef
9.
Zurück zum Zitat Irino T, Hiki N, Nunobe S, Ohashi M, Tanimura S, Sano T, Yamaguchi T (2014) Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer. J Gastrointest Surg 18:1429–1433CrossRef Irino T, Hiki N, Nunobe S, Ohashi M, Tanimura S, Sano T, Yamaguchi T (2014) Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer. J Gastrointest Surg 18:1429–1433CrossRef
10.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRef
11.
Zurück zum Zitat Ikeguchi M, Kondou A, Shibata S, Yamashiro H, Tsujitani S, Maeta M, Kaibara N (1994) Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 73:15–21CrossRef Ikeguchi M, Kondou A, Shibata S, Yamashiro H, Tsujitani S, Maeta M, Kaibara N (1994) Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 73:15–21CrossRef
12.
Zurück zum Zitat Han SL, Hua YW, Wang CH, Ji SQ, Zhuang J (2003) Metastatic pattern of lymph node and surgery for gastric stump cancer. J Surg Oncol 82:241–246CrossRef Han SL, Hua YW, Wang CH, Ji SQ, Zhuang J (2003) Metastatic pattern of lymph node and surgery for gastric stump cancer. J Surg Oncol 82:241–246CrossRef
13.
Zurück zum Zitat Honda S, Bando E, Makuuchi R, Tokunaga M, Tanizawa Y, Kawamura T, Sugiura T, Kinugasa Y, Uesaka K, Terashima M (2017) Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach. Gastric Cancer 20:457–464CrossRef Honda S, Bando E, Makuuchi R, Tokunaga M, Tanizawa Y, Kawamura T, Sugiura T, Kinugasa Y, Uesaka K, Terashima M (2017) Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach. Gastric Cancer 20:457–464CrossRef
14.
Zurück zum Zitat Nakamura M, Hosoya Y, Yano M, Doki Y, Miyashiro I, Kurashina K, Morooka Y, Kishi K, Lefor AT (2011) Extent of gastric resection impacts patient quality of life: the dysfunction after upper gastrointestinal surgery for cancer (DAUGS 32) scoring system. Ann Surg Oncol 18:314–320CrossRef Nakamura M, Hosoya Y, Yano M, Doki Y, Miyashiro I, Kurashina K, Morooka Y, Kishi K, Lefor AT (2011) Extent of gastric resection impacts patient quality of life: the dysfunction after upper gastrointestinal surgery for cancer (DAUGS 32) scoring system. Ann Surg Oncol 18:314–320CrossRef
15.
Zurück zum Zitat Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A (2011) Assessment of quality of life after gastrectomy using EORTC QLQ- C 30 and STO 22. World J Surg 35:357–364CrossRef Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A (2011) Assessment of quality of life after gastrectomy using EORTC QLQ- C 30 and STO 22. World J Surg 35:357–364CrossRef
16.
Zurück zum Zitat Kosuga T, Hiki N, Nunobe S, Noma H, Honda M, Tanimura S, Sano T, Yamaguchi T (2014) Feasibility and nutritional impact of laparoscopy- assisted subtotal gastrectomy for early gastric cancer in the upper stomach. Ann Surg Oncol 21:2028–2035CrossRef Kosuga T, Hiki N, Nunobe S, Noma H, Honda M, Tanimura S, Sano T, Yamaguchi T (2014) Feasibility and nutritional impact of laparoscopy- assisted subtotal gastrectomy for early gastric cancer in the upper stomach. Ann Surg Oncol 21:2028–2035CrossRef
17.
Zurück zum Zitat Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (London) 402:656–660CrossRef Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (London) 402:656–660CrossRef
18.
Zurück zum Zitat Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, Mori M, Doki Y (2010) Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 138:1312–1320CrossRef Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, Mori M, Doki Y (2010) Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 138:1312–1320CrossRef
19.
Zurück zum Zitat Takiguchi S, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Hosoda H, Kangawa K, Mori M, Doki Y (2016) Impact of synthetic ghrelin administration for patients with severe body weight reduction more than 1 year after gastrectomy: a phase II clinical trial. Surg Today 46:379–385CrossRef Takiguchi S, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Hosoda H, Kangawa K, Mori M, Doki Y (2016) Impact of synthetic ghrelin administration for patients with severe body weight reduction more than 1 year after gastrectomy: a phase II clinical trial. Surg Today 46:379–385CrossRef
20.
Zurück zum Zitat Takiguchi S, Adachi S, Yamamoto K, Morii E, Miyata H, Nakajima K, Yamasaki M, Kangawa K, Mori M, Doki Y (2012) Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci 57:1238–1246CrossRef Takiguchi S, Adachi S, Yamamoto K, Morii E, Miyata H, Nakajima K, Yamasaki M, Kangawa K, Mori M, Doki Y (2012) Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci 57:1238–1246CrossRef
21.
Zurück zum Zitat Lee JY, Choi IJ, Cho SJ, Kim CG, Kook MC, Lee JH, Ryu KW, Kim YW (2010) Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc 24:1360–1366CrossRef Lee JY, Choi IJ, Cho SJ, Kim CG, Kook MC, Lee JH, Ryu KW, Kim YW (2010) Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc 24:1360–1366CrossRef
22.
Zurück zum Zitat Nishide N, Ono H, Kakushima N, Takizawa K, Tanaka M, Matsubayashi H, Yamaguchi Y (2012) Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in remnant stomach or gastric tube. Endoscopy 44:577–583CrossRef Nishide N, Ono H, Kakushima N, Takizawa K, Tanaka M, Matsubayashi H, Yamaguchi Y (2012) Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in remnant stomach or gastric tube. Endoscopy 44:577–583CrossRef
23.
Zurück zum Zitat Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Hyung WJ; Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group (2019) Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Hyung WJ; Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group (2019) Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol
24.
Zurück zum Zitat Kawase H, Ebihara Y, Shichinohe T, Nakamura F, Murakawa K, Morita T, Okushiba S, Hirano S (2017) Long-term outcome after laparoscopic gastrectomy: a multicenter retrospective study. Langenbeck's Arch Surg 402:41–47CrossRef Kawase H, Ebihara Y, Shichinohe T, Nakamura F, Murakawa K, Morita T, Okushiba S, Hirano S (2017) Long-term outcome after laparoscopic gastrectomy: a multicenter retrospective study. Langenbeck's Arch Surg 402:41–47CrossRef
25.
Zurück zum Zitat Tsunoda S, Okabe H, Tanaka E, Hisamori S, Harigai M, Murakami K, Sakai Y (2016) Laparoscopic gastrectomy for remnant gastric cancer: a comprehensive review and case series. Gastric Cancer 19:287–292CrossRef Tsunoda S, Okabe H, Tanaka E, Hisamori S, Harigai M, Murakami K, Sakai Y (2016) Laparoscopic gastrectomy for remnant gastric cancer: a comprehensive review and case series. Gastric Cancer 19:287–292CrossRef
26.
Zurück zum Zitat Kyogoku N, Ebihara Y, Shichinohe T, Nakamura F, Murakawa K, Morita T, Okushiba S, Hirano S (2018) Circular versus linear stapling in esophagojejunostomy after laparoscopic total gastrectomy for gastric cancer: a propensity score-matched study. Langenbeck's Arch Surg 403:463–471CrossRef Kyogoku N, Ebihara Y, Shichinohe T, Nakamura F, Murakawa K, Morita T, Okushiba S, Hirano S (2018) Circular versus linear stapling in esophagojejunostomy after laparoscopic total gastrectomy for gastric cancer: a propensity score-matched study. Langenbeck's Arch Surg 403:463–471CrossRef
27.
Zurück zum Zitat Hatao F, Chen KY, Wu JM, Wang MY, Aikou S, Onoyama H, Shimizu N, Fukatsu K, Seto Y, Lin MT (2017) Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients. Langenbeck's Arch Surg 402:203–211CrossRef Hatao F, Chen KY, Wu JM, Wang MY, Aikou S, Onoyama H, Shimizu N, Fukatsu K, Seto Y, Lin MT (2017) Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients. Langenbeck's Arch Surg 402:203–211CrossRef
28.
Zurück zum Zitat Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T (2017) Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbeck's Arch Surg 402:501–507CrossRef Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T (2017) Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbeck's Arch Surg 402:501–507CrossRef
Metadaten
Titel
Comparison of total versus subtotal gastrectomy for remnant gastric cancer
verfasst von
Hironobu Goto
Shingo Kanaji
Dai Otsubo
Taro Oshikiri
Masashi Yamamoto
Tetsu Nakamura
Satoshi Suzuki
Yasuhiro Fujino
Masahiro Tominaga
Yoshihiro Kakeji
Publikationsdatum
04.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2019
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-019-01821-x

Weitere Artikel der Ausgabe 6/2019

Langenbeck's Archives of Surgery 6/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.